A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, ChronicIntervention: Drug: Pegylated Interferon (PEG-IFN) alfa-2aSponsor: Hoffmann-La RocheCompleted - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2016 Category: Research Source Type: clinical trials